User Fee Bill Puts Industry, U.S. FDA to Work On Global Supply Chain Risks
This article was originally published in PharmAsia News
Executive Summary
The user fee legislation U.S. Congress approved June 26 makes quality risk management a GMP requirement, further pressuring pharmaceutical manufacturers to make sure they are protecting their global supply chains.